684 resultados para HEMOGLOBINA GLUCOSILADA
Resumo:
The objective of this work was to evaluate the inter-relationship between dietary supplementation with Saccharomyces cerevisiae cell wall and vaccination against Streptococcus agalactiae, and its effect on the productive performance and hematological variables of Nile tilapia (Oreochromis niloticus). Eighty-four Nile tilapia were distributed in 12 fiber boxes (n=7), in a 2x2x3 factorial arrangement, corresponding to two levels of supplementation with yeast cell wall, two types of inoculation, and three evaluation times. Fish were fed during 77 days. Vaccination of fish was done 60 days after feeding started. Fifteen days after vaccination, all fish were subjected to challenge with live strain of S. agalactiae, and 6, 24, and 48 hours after the challenge, blood was collected from the caudal vein for evaluations. Fish fed with supplemented diets show greater weight gain and specific growth rate, and the interaction between the diet and vaccination effects results in higher hematocrit, hemoglobin, and leukocyte rates.
Resumo:
The objective of this work was to evaluate the hematological and parasitological responses of tambacu (Colossoma macropomum x Piaractus mesopotamicus) subjected to catch-and-release stress and to different stocking densities in a catch-and-release system. Two hundred and ten fish with mean initial weight of 785.33±152.02 g and mean total length of 34.43±2.21 cm were maintained in ponds and divided into three groups: without fishing and low density (G1), with fishing and low density (G2), and with fishing and high density (G3). No significant differences were observed between the mean values for hemoglobin concentration, erythrocyte number, differential counting of leukocytes, and glucose. The fish from the G3 group showed higher parasite and thrombocyte numbers, and lower weight gain and hematocrit. The activity of catch-and-release, associated with high stocking density, can disrupt organic balance and animal performance, favoring parasitosis.
Resumo:
Pós-graduação em Fisiopatologia em Clínica Médica - FMB
Resumo:
Pós-graduação em Pesquisa e Desenvolvimento (Biotecnologia Médica) - FMB
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Pós-graduação em Enfermagem (mestrado profissional) - FMB
Resumo:
Pós-graduação em Saúde Coletiva - FMB
Resumo:
Pós-graduação em Ginecologia, Obstetrícia e Mastologia - FMB
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Objective - At evaluating the IL-10 production in maternal blood and placenta and correlate them with perinatal outcomes in pregnancies complicated by hyperglycemia, or with risk to developing it, differentiated by the glycemic mean (GM < or ≥ 100mg/dL). Method- 186 pregnant women were distributed into groups GM < 100 mg/dL and GM ≥ 100 mg/dL. We evaluated the GM, HbA1c levels, maternal and placental IL-10 and TNF-α and the correlation between placental cytokines and perinatal outcomes. Results - In maternal blood, the lower concentrations of IL-10 (1.01 ± 0.87 vs. 3.08 ± 5.57 pg / mL, p = 0.0019) were observed in GM ≥ 100 mg / dL group. Placental IL-10 was directly correlated with hemoglobin levels (r = 0.63, p = 0.02) and insulin (r = 0.78, p = 0.01) from umbilical cord and with Apgar scores 1 (r = 0.53, p = 0.0095) and Apgar 5 (r = 0.69, p = 0.0003). Conclusion - GM ≥ 100mg/dL was associated with decreased of maternal IL-10. Placental IL-10 was similar in both groups and correlated directly with hemoglobin and insulin and with Apgar scores of 1st. and 5th. minutes
Resumo:
A anemia falciforme é uma doença genética caracterizada por uma anemia hemolítica crônica e fenômenos vaso-oclusivos, que levam a crises dolorosas e à lesão tecidual crônica e progressiva. Tem sido relatado que pacientes com anemia falciforme apresentam aumento dos níveis circulantes de citocinas, incluindo fator de necrose tumoral-α (TNF-α). O principal fármaco utilizado no tratamento dessa anemia é a hidroxiuréia (HU), fonte exógena de óxido nítrico (NO) e responsável pela inibição da agregação de plaquetas e aumento dos níveis de hemoglobina fetal (HbF). Trabalhos prévios têm demonstrado a importância da subunidade 1,2,5-oxadiazol-N-óxido como doadora de óxido nítrico. Nesse contexto, o presente trabalho tem como objetivo sintetizar um novo derivado híbrido do 1,2,5-oxadiol-N-óxido para a formação de um composto útil para o tratamento dos processos preventivos contra agregação plaquetária exacerbado em pacientes falciformes